Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01-05

AUTHORS

C Dive, R A Smith, E Garner, T Ward, S St George-Smith, F Campbell, W Greenhalf, P Ghaneh, J P Neoptolemos

ABSTRACT

Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at −80 °C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23–57) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739–1698) U l−1) compared with the locally advanced (n=20; 748 (406–1150) U l−1) and resected (n=64; 612 (331–987) U l−1) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum–bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors. More... »

PAGES

577-582

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494

DOI

http://dx.doi.org/10.1038/sj.bjc.6605494

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049468358

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20051949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CA-19-9 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Keratin-18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Necrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dive", 
        "givenName": "C", 
        "id": "sg:person.01224224677.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224224677.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "R A", 
        "id": "sg:person.014067200621.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garner", 
        "givenName": "E", 
        "id": "sg:person.014272237217.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014272237217.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ward", 
        "givenName": "T", 
        "id": "sg:person.0713326752.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713326752.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK", 
          "id": "http://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "George-Smith", 
        "givenName": "S St", 
        "id": "sg:person.01264066631.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264066631.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "F", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Greenhalf", 
        "givenName": "W", 
        "id": "sg:person.01116776343.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "P", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "J P", 
        "id": "sg:person.0750565077.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2407-9-88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036560706", 
          "https://doi.org/10.1186/1471-2407-9-88"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048568465", 
          "https://doi.org/10.1038/nrc2066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016470081", 
          "https://doi.org/10.1038/sj.bjc.6605175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048363663", 
          "https://doi.org/10.1038/sj.bjc.6602363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-007-0437-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009637575", 
          "https://doi.org/10.1007/s00280-007-0437-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046268399", 
          "https://doi.org/10.1038/sj.bjc.6603129"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-01-05", 
    "datePublishedReg": "2010-01-05", 
    "description": "Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at \u221280\u2009\u00b0C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23\u201357) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739\u20131698)\u2009U\u2009l\u22121) compared with the locally advanced (n=20; 748 (406\u20131150)\u2009U\u2009l\u22121) and resected (n=64; 612 (331\u2013987)\u2009U\u2009l\u22121) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum\u2013bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6605494", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "102"
      }
    ], 
    "keywords": [
      "pancreatic cancer", 
      "M65 levels", 
      "CK18 levels", 
      "cytokeratin 18", 
      "poor overall survival", 
      "serum bilirubin levels", 
      "solid tumor types", 
      "median duration", 
      "metastatic disease", 
      "overall survival", 
      "obstructive jaundice", 
      "clinical biomarker studies", 
      "M30 levels", 
      "biomarker utility", 
      "tumor types", 
      "baseline levels", 
      "patients", 
      "confounding factors", 
      "significant association", 
      "cancer", 
      "biomarker studies", 
      "plasma storage", 
      "epithelial cells", 
      "plasma samples", 
      "duration", 
      "jaundice", 
      "levels", 
      "necrosis", 
      "CK18", 
      "disease", 
      "M65", 
      "months", 
      "univariate", 
      "biomarkers", 
      "survival", 
      "apoptosis", 
      "full length", 
      "immunoassay", 
      "association", 
      "cells", 
      "caspases", 
      "factors", 
      "study", 
      "utility", 
      "enzyme", 
      "presence", 
      "concentration", 
      "use", 
      "samples", 
      "consideration", 
      "types", 
      "analysis", 
      "length", 
      "range", 
      "storage", 
      "characterisation"
    ], 
    "name": "Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer", 
    "pagination": "577-582", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049468358"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6605494"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20051949"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6605494", 
      "https://app.dimensions.ai/details/publication/pub.1049468358"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6605494"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605494'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      99 URIs      85 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6605494 schema:about N08cc5b9cd070470a8796b30d39c49c2e
2 N26361005bf064e92bc1cea17677681a1
3 N56030319e2c74067a6cb33ec08dc4e8f
4 N5b7b4bbf779c4ada918d68137f2ec127
5 N62278d7b60c642b59589a76bb609dd63
6 N722dc3ab47d741eeb22ece4667e5eb98
7 N8d17d068c0484ea9b07dbabe1b5acfab
8 N9d2c0c05447b4d648c65080523b0b6a3
9 Nb4a2f00fc25d4e5892d7d346b8cb61a6
10 Nc71cce39bcee4ddf9e3feb8d016915cf
11 Ncd017ba3eb4644418b5b9757f7c5d7d6
12 Ndf1a8e2ae7a0467e9852334c9f82ed40
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N93c60e48cc1446779056d685487fdf8e
16 schema:citation sg:pub.10.1007/s00280-007-0437-4
17 sg:pub.10.1038/nrc2066
18 sg:pub.10.1038/sj.bjc.6602363
19 sg:pub.10.1038/sj.bjc.6603129
20 sg:pub.10.1038/sj.bjc.6605175
21 sg:pub.10.1186/1471-2407-9-88
22 schema:datePublished 2010-01-05
23 schema:datePublishedReg 2010-01-05
24 schema:description Background:Enzyme-linked immunoassays of full-length (M65) and/or caspase-cleaved (M30) cytokeratin 18 (CK18) released from epithelial cells undergoing necrosis and/or apoptosis, respectively, may have prognostic or predictive biomarker utility in a range of solid tumour types. Characterisation of baseline levels of circulating full length and cleaved CK18 specifically in patients with pancreatic cancer.Methods:Plasma samples from 103 patients with pancreatic cancer stored at −80 °C were assayed for M65 and M30 levels. The median (inter-quartile range (IQR)) duration of plasma storage was 34 (23–57) months. Patients with metastatic disease (n=19) were found to have greater median (IQR) M65 levels (1145 (739–1698) U l−1) compared with the locally advanced (n=20; 748 (406–1150) U l−1) and resected (n=64; 612 (331–987) U l−1) patients (P=0.002). Elevated M65 levels were associated with poorer overall survival on univariate (P<0.001) but not multivariate (P=0.202) analysis. M65 concentrations also exhibited significant associations with concurrent serum–bilirubin levels (P<0.001) and the duration of plasma storage (P<0.001).Conclusions:Baseline plasma CK18 levels in pancreatic cancer are affected by the presence of obstructive jaundice and prolonged plasma storage. Clinical biomarker studies utilising serial CK18 levels are warranted in pancreatic cancer, provided consideration is given to these potentially confounding factors.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N24eaf677ee914d7db361b923d9896b74
28 N4a496dd566944b61a3a681608a9b27f9
29 sg:journal.1017082
30 schema:keywords CK18
31 CK18 levels
32 M30 levels
33 M65
34 M65 levels
35 analysis
36 apoptosis
37 association
38 baseline levels
39 biomarker studies
40 biomarker utility
41 biomarkers
42 cancer
43 caspases
44 cells
45 characterisation
46 clinical biomarker studies
47 concentration
48 confounding factors
49 consideration
50 cytokeratin 18
51 disease
52 duration
53 enzyme
54 epithelial cells
55 factors
56 full length
57 immunoassay
58 jaundice
59 length
60 levels
61 median duration
62 metastatic disease
63 months
64 necrosis
65 obstructive jaundice
66 overall survival
67 pancreatic cancer
68 patients
69 plasma samples
70 plasma storage
71 poor overall survival
72 presence
73 range
74 samples
75 serum bilirubin levels
76 significant association
77 solid tumor types
78 storage
79 study
80 survival
81 tumor types
82 types
83 univariate
84 use
85 utility
86 schema:name Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
87 schema:pagination 577-582
88 schema:productId N1fe9e2185972460083add3facc9299f3
89 Nba4897723a3a47709e605e7fb700e8df
90 Ncd53a6d23dc54231a0104b0dcc73de7c
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049468358
92 https://doi.org/10.1038/sj.bjc.6605494
93 schema:sdDatePublished 2022-12-01T06:28
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N4afe6b581add4f5a86ffabd102ceb13c
96 schema:url https://doi.org/10.1038/sj.bjc.6605494
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N033ce28c242342f581c9a5a3cd9ca009 rdf:first sg:person.0646035141.16
101 rdf:rest N5780cf808232401da4806536e10dc35c
102 N08cc5b9cd070470a8796b30d39c49c2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Middle Aged
104 rdf:type schema:DefinedTerm
105 N1433f22b4d484623a748255ec7a37b6b rdf:first sg:person.014272237217.90
106 rdf:rest N5a1c776b9a404cd788a53e852a903b18
107 N1fe9e2185972460083add3facc9299f3 schema:name dimensions_id
108 schema:value pub.1049468358
109 rdf:type schema:PropertyValue
110 N21beacdb9bdc46cb83791569221329a2 rdf:first sg:person.014067200621.05
111 rdf:rest N1433f22b4d484623a748255ec7a37b6b
112 N232456d2d0a241b795de7eeb7f0af992 rdf:first sg:person.01264066631.22
113 rdf:rest N033ce28c242342f581c9a5a3cd9ca009
114 N24eaf677ee914d7db361b923d9896b74 schema:issueNumber 3
115 rdf:type schema:PublicationIssue
116 N26361005bf064e92bc1cea17677681a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Pancreatic Neoplasms
118 rdf:type schema:DefinedTerm
119 N4a496dd566944b61a3a681608a9b27f9 schema:volumeNumber 102
120 rdf:type schema:PublicationVolume
121 N4afe6b581add4f5a86ffabd102ceb13c schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N56030319e2c74067a6cb33ec08dc4e8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Biomarkers, Tumor
125 rdf:type schema:DefinedTerm
126 N5780cf808232401da4806536e10dc35c rdf:first sg:person.01116776343.06
127 rdf:rest N99c230e9955143518fdd747075da6b30
128 N5a1c776b9a404cd788a53e852a903b18 rdf:first sg:person.0713326752.55
129 rdf:rest N232456d2d0a241b795de7eeb7f0af992
130 N5b7b4bbf779c4ada918d68137f2ec127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Apoptosis
132 rdf:type schema:DefinedTerm
133 N62278d7b60c642b59589a76bb609dd63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Keratin-18
135 rdf:type schema:DefinedTerm
136 N722dc3ab47d741eeb22ece4667e5eb98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Necrosis
138 rdf:type schema:DefinedTerm
139 N798e553934044952a63b0c0bfe6fe822 rdf:first sg:person.0750565077.18
140 rdf:rest rdf:nil
141 N8d17d068c0484ea9b07dbabe1b5acfab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Male
143 rdf:type schema:DefinedTerm
144 N93c60e48cc1446779056d685487fdf8e rdf:first sg:person.01224224677.10
145 rdf:rest N21beacdb9bdc46cb83791569221329a2
146 N99c230e9955143518fdd747075da6b30 rdf:first sg:person.07372440237.86
147 rdf:rest N798e553934044952a63b0c0bfe6fe822
148 N9d2c0c05447b4d648c65080523b0b6a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Female
150 rdf:type schema:DefinedTerm
151 Nb4a2f00fc25d4e5892d7d346b8cb61a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 Nba4897723a3a47709e605e7fb700e8df schema:name doi
155 schema:value 10.1038/sj.bjc.6605494
156 rdf:type schema:PropertyValue
157 Nc71cce39bcee4ddf9e3feb8d016915cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Enzyme-Linked Immunosorbent Assay
159 rdf:type schema:DefinedTerm
160 Ncd017ba3eb4644418b5b9757f7c5d7d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name CA-19-9 Antigen
162 rdf:type schema:DefinedTerm
163 Ncd53a6d23dc54231a0104b0dcc73de7c schema:name pubmed_id
164 schema:value 20051949
165 rdf:type schema:PropertyValue
166 Ndf1a8e2ae7a0467e9852334c9f82ed40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Aged
168 rdf:type schema:DefinedTerm
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
173 schema:name Oncology and Carcinogenesis
174 rdf:type schema:DefinedTerm
175 sg:journal.1017082 schema:issn 0007-0920
176 1532-1827
177 schema:name British Journal of Cancer
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.01116776343.06 schema:affiliation grid-institutes:grid.415970.e
181 schema:familyName Greenhalf
182 schema:givenName W
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116776343.06
184 rdf:type schema:Person
185 sg:person.01224224677.10 schema:affiliation grid-institutes:grid.5379.8
186 schema:familyName Dive
187 schema:givenName C
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224224677.10
189 rdf:type schema:Person
190 sg:person.01264066631.22 schema:affiliation grid-institutes:grid.5379.8
191 schema:familyName George-Smith
192 schema:givenName S St
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264066631.22
194 rdf:type schema:Person
195 sg:person.014067200621.05 schema:affiliation grid-institutes:grid.415970.e
196 schema:familyName Smith
197 schema:givenName R A
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05
199 rdf:type schema:Person
200 sg:person.014272237217.90 schema:affiliation grid-institutes:grid.415970.e
201 schema:familyName Garner
202 schema:givenName E
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014272237217.90
204 rdf:type schema:Person
205 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.415970.e
206 schema:familyName Campbell
207 schema:givenName F
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
209 rdf:type schema:Person
210 sg:person.0713326752.55 schema:affiliation grid-institutes:grid.5379.8
211 schema:familyName Ward
212 schema:givenName T
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713326752.55
214 rdf:type schema:Person
215 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.415970.e
216 schema:familyName Ghaneh
217 schema:givenName P
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
219 rdf:type schema:Person
220 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.415970.e
221 schema:familyName Neoptolemos
222 schema:givenName J P
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
224 rdf:type schema:Person
225 sg:pub.10.1007/s00280-007-0437-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009637575
226 https://doi.org/10.1007/s00280-007-0437-4
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/nrc2066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048568465
229 https://doi.org/10.1038/nrc2066
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/sj.bjc.6602363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048363663
232 https://doi.org/10.1038/sj.bjc.6602363
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/sj.bjc.6603129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046268399
235 https://doi.org/10.1038/sj.bjc.6603129
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/sj.bjc.6605175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016470081
238 https://doi.org/10.1038/sj.bjc.6605175
239 rdf:type schema:CreativeWork
240 sg:pub.10.1186/1471-2407-9-88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036560706
241 https://doi.org/10.1186/1471-2407-9-88
242 rdf:type schema:CreativeWork
243 grid-institutes:grid.415970.e schema:alternateName Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK
244 Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK
245 schema:name Department of Pathology, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK
246 Liverpool Experimental Cancer Medicines Centre and NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, Liverpool L69 3GA, UK
247 rdf:type schema:Organization
248 grid-institutes:grid.5379.8 schema:alternateName Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK
249 schema:name Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...